Point72 Hong Kong’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,795
Closed -$1.02M 443
2025
Q1
$1.02M Buy
+3,795
New +$1.02M 0.07% 196
2024
Q2
Sell
-15,971
Closed -$2.39M 428
2024
Q1
$2.39M Buy
+15,971
New +$2.39M 0.12% 183
2022
Q4
Sell
-44,547
Closed -$8.92M 89
2022
Q3
$8.92M Buy
+44,547
New +$8.92M 0.31% 46
2021
Q4
Sell
-3,900
Closed -$736K 1306
2021
Q3
$736K Buy
3,900
+3,470
+807% +$655K 0.02% 315
2021
Q2
$73K Buy
+430
New +$73K ﹤0.01% 831
2021
Q1
Sell
-453
Closed -$59K 1257
2020
Q4
$59K Sell
453
-129
-22% -$16.8K ﹤0.01% 716
2020
Q3
$85K Sell
582
-20,074
-97% -$2.93M 0.01% 585
2020
Q2
$3.06M Buy
+20,656
New +$3.06M 0.34% 59
2020
Q1
Sell
-7
Closed -$1K 926
2019
Q4
$1K Sell
7
-2,718
-100% -$388K ﹤0.01% 1088
2019
Q3
$219K Sell
2,725
-543
-17% -$43.6K 0.06% 274
2019
Q2
$237K Buy
+3,268
New +$237K 0.06% 278
2018
Q4
Sell
-72
Closed -$6K 865
2018
Q3
$6K Sell
72
-290
-80% -$24.2K ﹤0.01% 686
2018
Q2
$36K Buy
+362
New +$36K 0.01% 480
2018
Q1
Sell
-1,100
Closed -$140K 875
2017
Q4
$140K Buy
1,100
+560
+104% +$71.3K 0.11% 75
2017
Q3
$63K Sell
540
-96
-15% -$11.2K 0.04% 210
2017
Q2
$51K Sell
636
-223
-26% -$17.9K 0.05% 215
2017
Q1
$44K Buy
859
+572
+199% +$29.3K 0.06% 260
2016
Q4
$11K Sell
287
-447
-61% -$17.1K 0.01% 638
2016
Q3
$50K Sell
734
-5,701
-89% -$388K 0.03% 470
2016
Q2
$357K Buy
6,435
+400
+7% +$22.2K 0.41% 54
2016
Q1
$379K Buy
+6,035
New +$379K 0.74% 41
2015
Q3
Sell
-706
Closed -$85K 120
2015
Q2
$85K Buy
706
+100
+17% +$12K 0.17% 101
2015
Q1
$63K Sell
606
-113
-16% -$11.7K 0.06% 183
2014
Q4
$70K Buy
+719
New +$70K 0.07% 361